DARPA Awards Aethlon $6.8M for Technology to Combat Sepsis

10/4/11Follow @bvbigelow

The Pentagon’s Defense Advance Research Projects Agency (DARPA) has awarded a $6.8 million contract to San Diego’s Aethlon Medical to develop a medical device that could be used to reduce the incidence of sepsis, a potentially fatal bloodstream infection.

In a statement today, Aethlon says sepsis often the cause of death in combat-injured soldiers.

Aethlon says it will use its adaptive dialysis-like affinity platform technology as the basis for a blood purification system capable of filtering multiple sepsis-enabling particles from circulation. Developing such technology falls under the auspices of DARPA’s Dialysis-Like Therapeutics program, and is intended to dramatically reduce sepsis-induced morbidity and mortality.

Aethlon says it plans to incorporate a new blood pump strategy to reduce or eliminate the systemic administration of anticoagulants normally required during dialysis and other extracorporeal device therapies.

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788 Follow @bvbigelow

By posting a comment, you agree to our terms and conditions.